Source: Annual Congress 2003 - Lung structure and biology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. S. Zunic, G. V. Djordjevic-Denic, S. S. Zunic, S. Ruzdijic, L. M. Rakic (Belgrade, Yugoslavia). Cell profile and apoptotic markers evaluated by BAL in smoking and NSCLC. Eur Respir J 2003; 22: Suppl. 45, 574

Member's Comments

No comment yet.

Related content which might interest you: Cytotoxic phenotype of lymphocytes in bronchoalveolar lavage (BAL) of patients with non-small cell lung cancer (NSCLC) Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Diagnostic value of tumor markers and cells population in bronchoalveolar lavage in lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 37s Year: 2003 Apoptosis of circulating and BALF lymphocytes of patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 44s Year: 2004 The influence of smoking on the cell profile and selected surface markers in induced sputum Source: Eur Respir J 2004; 24: Suppl. 48, 81s Year: 2004 Relationship between blood monocyte subsets with activation markers and macrophages in non-small cell lung cancer Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Lower APCR correlates with apoptotic activation of CD8+T cells in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 356s Year: 2004 Gene expression profiles in non-small cell lung cancer (NSCLC) and lung tissue in smokers and non-smokers Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Inflammasome pathway activation in patients with non-small cell lung cancer (NSCLC): A bronchoalveolar lavage fluid study Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Evaluation of IL-10 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Promotion of artificial intelligence method in pattern recognition of BAL apoptotic parameters in smoking and NSCLC Source: Annual Congress 2007 - Lung injury and repair: from in vitro to in vivo Year: 2007 Clinical evaluation of the plasma levels of hTERT and EGFR expression as markers for early detection of non-small cell lung cancer Source: Annual Congress 2009 - Basic science and lung cancer Year: 2009 Prognostic value of apoptotic index in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 5s Year: 2004 Concordance of p53 and K-ras mutations in induced sputum and corresponding biopsies of patients with nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Differences in gene expression profiles in non-small cell lung cancer (NSCLC) and in corresponding healthy lung tissue in smokers and non-smokers Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer Year: 2010 Cytokine profile in lung cancer microenvironment- analysis of bronchoalveolar lavage fluid by Luminex assay Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 Identifying the sputum and BALF cell subpopulation with somatic DNA alterations in COPD Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009 Gene expression profiling in non-small cell lung cancer (NSCLC) according to smoking status Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics Year: 2008 Increased expression of WSX1 on alveolar lymphocytes (AL) in patients with early stage non-small cell lung cancer (NSCLC). Preliminary report Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014